Evidence map›Paper›PMID 26289589›Full record

ArticleMolecular brain2015

Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies.

Daisuke Nishizawa, Shinya Kasai, Junko Hasegawa, Naomi Sato, Hidetaka Yamada, Fumihiko Tanioka, Makoto Nagashima, Ryoji Katoh, Yasuo Satoh, Megumi Tagami and 30 more

Open access · goldAbstract read
In one paragraph

Article in Molecular brain, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Sleep-mediated regulation of reward circuits: implications in substance use disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Review
  10. Article
  11. Genetics of Smoking Behaviors in American Indians.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  12. Review
  13. Neuropsychiatric disease and treatment · 2020
    Article
  14. Genome-wide meta-analysis identifies a novel susceptibility signal at CACNA2D3 for nicotine dependence.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2017
    Article
  15. Review
  16. Orexin/Hypocretin System: Role in Food and Drug Overconsumption.International review of neurobiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 20 institutions in 1 country.

Daisuke NishizawaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. nishizawa-ds@igakuken.or.jp.
Shinya KasaiAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. kasai-sy@igakuken.or.jp.
Junko HasegawaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. hasegawa-jk@igakuken.or.jp.
Naomi SatoDepartment of Clinical Nursing, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan. naomi25@hama-med.ac.jp.
Hidetaka YamadaDepartment of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan. h-yamada@hama-med.ac.jp.
Fumihiko TaniokaDepartment of Pathology, Iwata City Hospital, Iwata, 438-8550, Japan. kyon8@juno.ocn.ne.jp.
Makoto NagashimaDepartment of Surgery, Toho University Sakura Medical Center, Sakura, 285-8741, Japan. nagashima@sakura.med.toho-u.ac.jp.
Ryoji KatohDepartment of Surgery, Toho University Sakura Medical Center, Sakura, 285-8741, Japan. ryochan@sakura.med.toho-u.ac.jp.
Yasuo SatohDepartment of Anesthesiology, Toho University Sakura Medical Center, Sakura, 285-8741, Japan. satoh-ane@sakura.med.toho-u.ac.jp.
Megumi TagamiDepartment of Anesthesiology, Toho University Sakura Medical Center, Sakura, 285-8741, Japan. tagami@sakura.med.toho-u.ac.jp.
Hiroshi UjikeUjike Nishiguchi Clinic, Okayama, 700-0024, Japan. hujike-10@t.okadai.jp.
Norio OzakiDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. ozaki-n@med.nagoya-u.ac.jp.
Toshiya InadaDepartment of Psychiatry, Seiwa Hospital, Institute of Neuropsychiatry, Tokyo, 162-0851, Japan. inada@seiwa-hp.com.
Nakao IwataDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, 470-1192, Japan. nakao@fujita-hu.ac.jp.
Ichiro SoraAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. sora@med.kobe-u.ac.jp.
Masaomi IyoDepartment of Psychiatry, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan. iyom@faculty.chiba-u.jp.
Mitsuhiko YamadaDepartment of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, 187-8553, Japan. mitsu@ncnp-k.go.jp.
Naoki KondoSeimei Hospital, Fuji City, 417-0801, Japan. waveonlyjust@yahoo.co.jp.
Moo-Jun WonKoujin Hospital, Nagoya, 463-8530, Japan. wonmj@hm10.aitai.ne.jp.
Nobuya NaruseSaitama Seishin-iryo Center, Kita-adachi, Saitama, 362-0806, Japan. naruse.nobuya@pref.saitama.lg.jp.
Kumi Uehara-AoyamaKanagawa Psychiatric Center, Serigaya Hospital, Kanagawa, 233-0006, Japan. kums@ballade.plala.or.jp.
Masanari ItokawaSchizophrenia and Depression Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan. itokawa-ms@igakuken.or.jp.
Kazutaka OhiDepartment of Psychiatry, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan. ohi@psy.med.osaka-u.ac.jp.
Ryota HashimotoDepartment of Psychiatry, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan. hashimor@psy.med.osaka-u.ac.jp.
Kumpei TanisawaDepartment of Genomics for Longevity and Health, Tokyo Metropolitan Institute of Gerontology, Tokyo, 173-0015, Japan. kunpei-tanisawa@fuji.waseda.jp.
Tomio AraiDepartment of Pathology, Tokyo Metropolitan Geriatric Hospital, Tokyo, 173-0015, Japan. arai@tmig.or.jp.
Seijiro MoriCenter for Promotion of Clinical Investigation, Tokyo Metropolitan Geriatric Hospital, Tokyo, 173-0015, Japan. mori_seijiro@tmghig.jp.
Motoji SawabeMolecular Pathophysiology, Department of Molecular-genetic Sciences, Division of Biomedical Laboratory Sciences, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, 101-0062, Japan. m.sawabe.mp@tmd.ac.jp.
Makiko Naka-MienoDepartment of Medical Informatics, Center for Information, Jichi Medical University, Shimotsuke, 329-0498, Japan. mnaka@jichi.ac.jp.
Yoshiji YamadaDepartment of Human Functional Genomics, Life Science Research Center, Mie University, Tsu, 514-8507, Japan. yamada@gene.mie-u.ac.jp.
Miki YamadaDepartment of Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, 101-0062, Japan. myamada.epi@mri.tmd.ac.jp.
Noriko SatoDepartment of Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, 101-0062, Japan. nsato.epi@mri.tmd.ac.jp.
Masaaki MuramatsuDepartment of Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, 101-0062, Japan. muramatsu.epi@mri.tmd.ac.jp.
Masashi TanakaDepartment of Genomics for Longevity and Health, Tokyo Metropolitan Institute of Gerontology, Tokyo, 173-0015, Japan. mtanaka@tmig.or.jp.
Yoko Irukayama-TomobeInternational Institute of Integrative Sleep Medicine, Ibaraki, 305-8575, Japan. irukayama.yoko.fm@u.tsukuba.ac.jp.
Yuki C SaitoDepartment of Molecular Neuroscience and Integrative Physiology, Faculty of Medicine, Kanazawa University, Ishikawa, 920-8640, Japan. y.cleo1115@gmail.com.
Takeshi SakuraiDepartment of Molecular Neuroscience and Integrative Physiology, Faculty of Medicine, Kanazawa University, Ishikawa, 920-8640, Japan. tsakurai@med.kanazawa-u.ac.jp.
Masakazu HayashidaDepartment of Anesthesiology and Pain Medicine, Juntendo University School of Medicine, Tokyo, 113-8421, Japan. hayashidatoday@yahoo.co.jp.
Haruhiko SugimuraDepartment of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan. hsugimur@hama-med.ac.jp.
Kazutaka IkedaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. ikeda-kz@igakuken.or.jp.
Tokyo Medical and Dental University · JPTokyo Metropolitan Institute of Medical Science · JPHamamatsu University School of Medicine · JPToho University Medical Center Sakura Hospital · JPKanazawa University · JPOsaka University · JPTokyo Metropolitan Geriatric Hospital · JPTokyo Metropolitan Institute of Gerontology · JPChiba University · JPFujita Health University · JPIwata City Hospital · JPJichi Medical University · JPJuntendo University · JPKobe University · JPKoujin Hospital · JPMie University · JPNagoya University · JPNational Institute of Mental Health · JPSeiwa Hospital · JPToho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany genetic and environmental factors are involved in the etiology of nicotine dependence. Although several candidate gene variations have been reported by candidate gene studies or genome-wide association studies (GWASs) to be associated with smoking behavior and the vulnerability to nicotine dependence, such studies have been mostly conducted with subjects with European ancestry. However, genetic factors have rarely been investigated for the Japanese population as GWASs. To elucidate genetic factors involved in nicotine dependence in Japanese, the present study comprehensively explored genetic contributors to nicotine dependence by using whole-genome genotyping arrays with more than 200,000 markers in Japanese subjects.

resultsThe subjects for the GWAS and replication study were 148 and 374 patients, respectively. A two-stage GWAS was conducted using the Fagerström Test for Nicotine Dependence (FTND), Tobacco Dependence Screener (TDS), and number of cigarettes smoked per day (CPD) as indices of nicotine dependence. For the additional association analyses, patients who underwent major abdominal surgery, patients with methamphetamine dependence/psychosis, and healthy subjects with schizotypal personality trait data were recruited. Autopsy specimens with various diseases were also evaluated. After the study of associations between more than 200,000 marker single-nucleotide polymorphisms (SNPs) and the FTND, TDS, and CPD, the nonsynonymous rs2653349 SNP (located on the gene that encodes orexin [hypocretin] receptor 2) was selected as the most notable SNP associated with FTND, with a p value of 0.0005921 in the two-stage GWAS. This possible association was replicated for the remaining 374 samples. This SNP was also associated with postoperative pain, the initiation of methamphetamine use, schizotypal personality traits, and susceptibility to goiter.

conclusionsAlthough the p value did not reach a conventional genome-wide level of significance in our two-stage GWAS, we obtained significant results in the subsequent analyses that suggest that the rs2653349 SNP (Val308Ile) could be a genetic factor that is related to nicotine dependence and possibly pain, schizotypal personality traits, and goiter in the Japanese population.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyAbdomenAdolescentAdultAgedAged, 80 and overAsian PeopleAutopsyFemaleGenetic LociGoiterHumansMaleMethamphetamineMiddle AgedMethamphetamineOrexin Receptors

Identifiers

PMID26289589
PMCPMC4546081
OpenAlexW2157396449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.